Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/60034
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhatale, Pravin N-
dc.contributor.authorBhajipale, Nitin S-
dc.contributor.authorThangavel, Sivakumar-
dc.contributor.authorThangavelu, Prabha-
dc.contributor.authorMahajan, N S-
dc.date.accessioned2022-07-05T10:53:48Z-
dc.date.available2022-07-05T10:53:48Z-
dc.date.issued2022-06-
dc.identifier.issn2583-1321 (Online); 0019-5103 (Print)-
dc.identifier.urihttp://nopr.niscpr.res.in/handle/123456789/60034-
dc.description607-616en_US
dc.description.abstractIn the present study, novel series of 5-{[4-(acetylamino) phenoxy] methyl}-1,3,4-oxadiazole-2-yl-sulfanyl-N-substituted-2-acetamide/2-propanamide/3-propanamide derivatives (8a to 8c, 9a to 9c and 10a to 10c) have been synthesized.The newly synthesized compounds have been tested for their anti-inflammatory and anti-ulcerogenic activities in vivo.Among the present series the compound 8c is found to be most active against inflammation with inhibition of 65.34% andhas been observed to be safe ulcerogenically. It is observed that introduction of an asymmetric centre near the sulfur atomdecreases the activity. Molecular docking simulations have been carried out for the compounds. Structures from all theseries fit into the active site of cyclooxygenase-2 enzyme with least binding energies and exhibit favorable bindinginteractions required for the selective inhibition of cyclooxygenase- 2.en_US
dc.language.isoenen_US
dc.publisherNIScPR-CSIR, Indiaen_US
dc.sourceIJC Vol.61(06) [June 2022]en_US
dc.subject1,3,4-Oxadiazoleen_US
dc.subjectcyclooxygenase-2en_US
dc.subjectanti-inflammatoryen_US
dc.subjectdockingen_US
dc.subjectMOEen_US
dc.titleSynthesis, antiinflammatory evaluation and docking analysis of some novel 1,3,4-oxadiazole derivativesen_US
dc.typeArticleen_US
Appears in Collections:IJC Vol.61(06) [June 2022]

Files in This Item:
File Description SizeFormat 
IJC 61(6) 607-616.pdf2.31 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.